This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

Andrew Dakos Biography and Net Worth

Director of High Income Securities Fund

Andrew Dakos serves as President, Director of the Company. Mr. Dakos has been the President and a Director of SPE since 2009. He is also a Member of the Adviser. Mr. Dakos has over 15 years of investment management experience. He is currently a principal of Bulldog Holdings, LLC, which owns several entities serving as general partner of five private investment partnerships. Mr. Dakos is also a director of two other closed-end funds, one subsidiary of a large commercial real estate company and one liquidating trust.

What is Andrew Dakos' net worth?: The estimated net worth of Andrew Dakos is at least $140,335.00 as of January 20th, 2021. Mr. Dakos owns 22,100 shares of High Income Securities Fund stock worth more than $140,335 as of April 25th. This net worth approximation does not reflect any other assets that Mr. Dakos may own. Learn More about Andrew Dakos' net worth.
How do I contact Andrew Dakos?: The corporate mailing address for Mr. Dakos and other High Income Securities Fund executives is , , . High Income Securities Fund can also be reached via phone at 617-292-1000. Learn More on Andrew Dakos' contact information.
Has Andrew Dakos been buying or selling shares of High Income Securities Fund?: Andrew Dakos has not been actively trading shares of High Income Securities Fund during the last quarter. Most recently, Andrew Dakos sold 20,000 shares of the business's stock in a transaction on Wednesday, September 15th. The shares were sold at an average price of $9.96, for a transaction totalling $199,200.00. Learn More on Andrew Dakos' trading history.
Who are High Income Securities Fund's active insiders?: High Income Securities Fund's insider roster includes Andrew Dakos (Director), Phillip Goldstein (Director), and Gerald Hellerman (Director). Learn More on High Income Securities Fund's active insiders.
Are insiders buying or selling shares of High Income Securities Fund?: During the last year, High Income Securities Fund insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $6,170.00. The most recent insider tranaction occured on May, 4th when Director Moritz A Sell bought 1,000 shares worth more than $6,170.00. Insiders at High Income Securities Fund own 15.4% of the company. Learn More about insider trades at High Income Securities Fund.
Information on this page was last updated on 5/4/2023.

Andrew Dakos Insider Trading History at High Income Securities Fund

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/15/2021	Sell	20,000	$9.96	$199,200.00
9/13/2021	Sell	10,000	$9.94	$99,400.00
1/20/2021	Sell	1,900	$8.72	$16,568.00	22,100
12/17/2020	Sell	1,299	$8.96	$11,639.04	25,299
10/14/2020	Sell	5,000	$8.40	$42,000.00	35,299
9/30/2020	Sell	15,389	$8.33	$128,190.37
9/28/2020	Sell	10,000	$8.33	$83,300.00	43,507
9/21/2020	Sell	5,303	$8.45	$44,810.35	60,000
9/18/2020	Sell	1,190	$8.54	$10,162.60	60,000

Andrew Dakos Buying and Selling Activity at High Income Securities Fund

High Income Securities Fund Company Overview

High Income Securities Fund is a closed-ended balanced income mutual fund launched and managed by Putnam Investment Management, LLC. The fund is co-managed by Putnam Investments Limited. It invests in the fixed income markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It invests in both convertible bonds and convertible preferred stocks. The fund benchmarks the performance of its portfolio against a composite index comprising of 50% JPMorgan Developed High Yield Index and 50% BofA Merrill Lynch AllConvertibles Speculative Quality Index. The fund was formerly known as Putnam High Income Securities Fund High Income Securities Fund was formed on July 9, 1987 and is domiciled in the United States.

Today's Range

Now: $6.35

$6.30

$6.39

50 Day Range

MA: $6.60

$6.20

$6.96

2 Week Range

Now: $6.35

$5.71

$6.96

Volume

156,773 shs

Average Volume

96,405 shs

Market Capitalization

$111.32 million

P/E Ratio

N/A

Dividend Yield

11.62%

Beta

0.89

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad